Raed Dweik, MD

Chair, Innovation Management and Conflict of Interest

Dr. Dweik's executive experiences include serving on the Board of Governors, Board of Trustees and Board of Directors of the Cleveland Clinic Health System and chairing the system's Innovation Management and Conflict of Interest.
Raed Dweik, MD
  • Watch Video
  • Dr. Dweik's executive experiences include serving on the Board of Governors, Board of Trustees and Board of Directors of the Cleveland Clinic Health System and chairing the system's Innovation Management and Conflict of Interest.
Location
Biography

About Raed Dweik, MD

Raed Dweik, MD, MBA is the Interim Chair of Cleveland Clinic’s Respiratory Institute (RI) which has over 650 employees including 172 faculty members, 72 advanced practice providers and 49 fellows in four departments: Pulmonary Medicine, Critical Care Medicine, Infectious Disease, and Allergy/Immunology.  The clinical activities of the RI are conducted at Cleveland Clinic’s main campus, as well as eight Cleveland Clinic Health System hospitals and 15 freestanding multispecialty outpatient facilities.  Annually, we perform over 200,000 outpatient visits, 60,000 pulmonary function tests, 5,000 bronchoscopies, and 120 lung transplants.  We have a daily hospital census of over 350 inpatient beds including over 150 patients in medical intensive care units (MICUs) across the system. In addition to providing general pulmonary, critical care, infectious disease and allergy services, the RI provides advanced subspecialty services that attract patients from throughout the United States and several countries. Over 20 percent of the Institute’s patients come from outside of Northeast Ohio. The educational activities of the RI include five fellowship programs in pulmonary and critical care (24 fellows), critical care (12 total fellows), infectious disease (8 fellows), allergy and clinical immunology (4 fellows), and advanced interventional bronchoscopy (1 fellow).  The RI conducts a broad spectrum of research activities across the spectrum of basic, translational, and clinical research (including multicenter clinical trials). The research is supported by over 60 federal grants, 50 industry sponsored trials, and various foundation awards.

Dr. Dweik's clinical interests include pulmonary hypertension, asthma, chronic beryllium disease and critical care and he regularly attends in the medical intensive care unit (MICU).  He is board certified in internal medicine, pulmonary disease and critical care medicine and has been listed in The Best Doctors in America since 2005.

Dr. Dweik is Professor of Medicine at Cleveland Clinic Lerner College of Medicine and has a joint appointment in the Lerner Research Institute (LRI) with continuous funding from the NIH since 2002.  He established a Research Center of Excellence in Pulmonary Vascular Disease including a patient registry, a human sample biorepository and an animal model core. He was the recipient of the Cleveland Clinic Outstanding Innovation in Translational Medicine Award and a Third Frontier Award from the state of Ohio for his pioneering work in exhaled breath analysis in lung and systemic disease. He has published over 250 peer reviewed manuscripts and book chapters and serves on several journal editorial boards, National Institutes of Health (NIH) review panels and American Thoracic Society (ATS), American Heart Association (AHA), and Association of American Medical Colleges (AAMC) committees. 

Dr. Dweik is the recipient of many teaching awards including the Cleveland Clinic Distinguished Teacher Award from the Internal Medicine Residency Program for five times, the Teacher of the Year Award from the Pulmonary Fellowship Program and the Scholarship in Teaching Award from Case Western Reserve University. He is Director of the KL2 program of the Cleveland Clinical and Translational Science Collaborative (CTSC), a member of the admissions committee at CCLCM, and past chair of the Committee on Advancement, Promotion and Tenure (CAPT) at Case Western Reserve University School of Medicine.

Dr. Dweik has served on the Board of Governors, Board of Trustees and Board of Directors of the Cleveland Clinic Health System and chairs the system's Innovation Management and Conflict of Interest committee (IM&COI), the routine Capital Review Committee (CRC) and the strategic capital Advisory Team (AT).

Dr. Dweik is a Fellow of the American College of Physicians (FACP), the Royal College of Physicians of Canada (FRCPC), the American College of Chest Physicians (FCCP), the Society of Critical Care Medicine (FCCM), the American Thoracic Society (ATSF), the American Heart Association (FAHA), the Pulmonary Vascular Research Institute (PVRI), and a founding member of the International Association for Breath Research (IABR).

After receiving his medical degree from the University of Jordan Faculty of Medicine, Dr. Dweik completed his internship and residency in internal medicine at Miami Valley Hospital and Wright State University in Dayton, OH. He completed his fellowship in pulmonary and critical care medicine at Cleveland Clinic.

Education & Professional Highlights

Education & Professional Highlights

Appointed
1996

Education & Fellowships

Graduate - Case Western Reserve University Weatherhead School of Management
MBA
Cleveland, OH USA
2017

Fellowship - Cleveland Clinic
Pulmonary Disease/Critical Car
Cleveland, OH USA
1996

Residency - Wright State University
Internal Medicine
Dayton, OH USA
1993

Internship - Miami Valley Hospital
Internal Medicine
Dayton, OH USA
1990

Internship - Jordan University Hospital
Rotating
Amman,
1989

Medical School - University of Jordan Faculty of Medicine
Amman, Jordan
1988

Professional Highlights

  • Executive:

    2015 Member, Cleveland Clinic Board of Directors Cleveland Clinic, Cleveland, OH
  • 2014-15 Member, Cleveland Clinic Board of Trustees Cleveland Clinic, Cleveland, OH
  • 2014- Chair, Innovation Management and Conflict of Interest, Cleveland Clinic Health System
  • 2011-15 Elected member: Cleveland Clinic Board of Governors
  • 2008-2013 Member, Respiratory Institute Executive Physician Committee
  • 2008-2013 Member, Respiratory Institute Administrative Council, Cleveland Clinic 

    Clinical and Academic:

    2016- Chair, Documents Development and implementation Committee (DDIC), American Thoracic Society (ATS)   
  • 2014- Director, KL2 Program and Chair, KL2 Steering Committee / Cleveland Clinical and Translational Science Collaborative (CTSC), Case Western Reserve University SOM
  • 2014-15 Chair, Committee on Appointment, Promotion, and Tenure (CAPT), Case Western Reserve University School of Medicine (CWRU-SOM)
  • 2014- Chair, Cleveland Clinic Standing Committee on Research Conduct and Quality
  • 2015- Chair, Cardiorenal and Lung Peer Review Committee, American Heart Association (AHA) 
  • 2015- Reviewer, Respiratory Integrative Biology and Translational Research, RIBT Study section, National Heart Lung and Blood Institute (NHLBI) - NIH   
  • 2009- Scientific Advisory Board (SAB) Member: Mid-Infrared Technologies for Health and the Environment, A National Science Foundation (NSF) – Engineering Research Center at Princeton University and Partners
  • 2008-2012: Third Frontier Award: Ohio Department of Development
  • 2005- Founding Member: International Association for Breath Research (IABR)
  • 2005-2010 Member / Reviewer, Special Emphasis Panel, Mentored Clinical Scientist Development Award (K08), National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH)
  • 2004- 2009 Member, Special Emphasis Panel, Mentored Patient Oriented Research Career Development Awards (K18, K23, K24 and K25) National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH)
  • 2003- Admissions Committee Member, Cleveland Clinic Lerner College of Medicine of CWRU

Certifications

  • Internal Medicine
  • Internal Medicine - Pulmonary Disease
  • Internal Medicine - Critical Care Medicine

Specialty Interests

Pulmonary hypertension, pulmonary vascular disease, asthma, beryllium disease, chronic beryllium disease, berylliosis, respiratory failure, ARDS, sepsis

Awards & Honors

  • Listed in "Best Doctors in America": 2005- Present
  • Distinguished Teacher Award Internal Medicine Residency Program: 2000-01, 2003-04, 2004-05, 2006-07, 2007-08. 
  • Teacher of the Year Award Pulmonary Fellowship Program: 2006-2007
  • Cleveland Clinic Foundation Innovator Award 2004
  • Lerner Research Institute STAR Award 2010

Innovations & Patents

  • Exhaled Breath Testing

Memberships

  • American College of Physicians, Fellow (FACP)
  • American College of Chest Physicians, Fellow (FCCP)
  • Royal College of Physicians of Canada, Fellow (FRCPC)
  • American Heart Association (AHA), Fellow (FAHA)
  • Society of Critical Care Medicine (SCCM), Fellow (FCCM)
  • Pulmonary Vascular Research Institute (PVRI), Fellow
  • American Thoracic Society (ATS), Member
  • American Association for the Advancement of Science, Member
  • American Physiological Society, Member
  • International Association for Breath Research, Founding Member
Research & Publications

Research & Publications

See publications for Raed Dweik, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/28/2018, Dr. Dweik has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Raed Dweik, MD

Related Videos Featuring Raed Dweik, MD

; ; ;